Categories: NewsPharmaceutical

Theratechnologies to Announce Second Quarter 2023 Financial Results and Provide Business Update

MONTREAL, June 29, 2023 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced it will report financial results and provide a business update for its second quarter ended May 31, 2023, on Wednesday, July 12 at 8:30 a.m. EDT.

The call will be hosted by Mr. Paul Lévesque, President and Chief Executive Officer. Mr. Lévesque will joined be other members of the management team, including Chief Financial Officer, Mr. Philippe Dubuc, Chief Medical Officer, Dr. Christian Marsolais and Global Commercial Officer, Mr. John Leasure, who will be available to answer questions from participants following prepared remarks.

Participants are encouraged to join the call at least ten minutes in advance to secure access.

Conference call dial-in and replay information is below:

CONFERENCE CALL INFORMATION
Conference Call Date July 12, 2023
Conference Call Time 8:30 a.m. EDT
Webcast link https://edge.media-server.com/mmc/p/ot7rcxmr
Dial in 1-888-317-6003 (toll free) or 1-412-317-6061 (international)
Access Code 0616524

An archived webcast will also be available on the Company’s Investor Relations website under ‘Past Events’.

About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company’s website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.

Contacts:

Investor inquiries:
Philippe Dubuc
Senior Vice President and Chief Financial Officer
ir@theratech.com
1-438-315-6608

Staff

Recent Posts

Cutera® Appoints Jeryl L. Hilleman to Board of Directors

Experienced Healthcare Executive Brings Extensive Financial and Operational Expertise to Cutera Board of DirectorsBRISBANE, Calif.--(BUSINESS…

1 hour ago

GE HealthCare Announces Changes in Strategic Leadership and Key Segments to Better Serve Patients and Customers

Roland Rott, the current president and CEO of Ultrasound, will lead Imaging, replacing Jan Makela…

1 hour ago

Glass Lens Market size is set to grow by USD 7.36 billion from 2024-2028, Rising elderly population boost the market, Technavio

NEW YORK, June 10, 2024 /PRNewswire/ -- The global glass lens market size is estimated to grow…

1 hour ago

GT Independence Expands Senior Leadership Team

Company appoints Pearl Barnett as Chief Operating Officer; Megan Owen becomes Chief Compliance Officer STURGIS,…

1 hour ago

Anne Bink, Former FEMA Official, Joins IEM

MORRISVILLE, N.C., June 10, 2024 /PRNewswire/ -- IEM International, Inc., a global leader in emergency…

1 hour ago